Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria

Delphine Girlich, Sandrine Bernabeu, Victor Grosperrin, Isabelle Langlois, Christine Begasse, Nicolas Arangia, Elodie Creton, Garance Cotellon, Aimie Sauvadet, Laurent Dortet, Thierry Naas
Karen C. Carroll, Editor
Delphine Girlich
aEA7361 “Structure, dynamic, function and expression of broad spectrum β-lactamases,” Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France
bEvolution and Ecology of Resistance to Antibiotics Unit, Institut Pasteur, APHP, Université Paris-Sud, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrine Bernabeu
aEA7361 “Structure, dynamic, function and expression of broad spectrum β-lactamases,” Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France
bEvolution and Ecology of Resistance to Antibiotics Unit, Institut Pasteur, APHP, Université Paris-Sud, Paris, France
cBacteriology-Hygiene Unit, Assistance Publique–Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
dAssociated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Grosperrin
aEA7361 “Structure, dynamic, function and expression of broad spectrum β-lactamases,” Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Langlois
cBacteriology-Hygiene Unit, Assistance Publique–Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Begasse
cBacteriology-Hygiene Unit, Assistance Publique–Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Arangia
cBacteriology-Hygiene Unit, Assistance Publique–Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elodie Creton
dAssociated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Garance Cotellon
dAssociated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aimie Sauvadet
dAssociated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Dortet
aEA7361 “Structure, dynamic, function and expression of broad spectrum β-lactamases,” Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France
bEvolution and Ecology of Resistance to Antibiotics Unit, Institut Pasteur, APHP, Université Paris-Sud, Paris, France
cBacteriology-Hygiene Unit, Assistance Publique–Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
dAssociated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Naas
aEA7361 “Structure, dynamic, function and expression of broad spectrum β-lactamases,” Université Paris-Sud, Université Paris-Saclay, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France
bEvolution and Ecology of Resistance to Antibiotics Unit, Institut Pasteur, APHP, Université Paris-Sud, Paris, France
cBacteriology-Hygiene Unit, Assistance Publique–Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France
dAssociated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thierry Naas
Karen C. Carroll
Johns Hopkins University School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01800-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

As carbapenemase-producing Gram-negative bacilli (CP-GNB) coproducing MCR-1 are now emerging and, thus, compromising the use of last-resort antibiotics (carbapenems and colistin), there is an urgent need for accurate and fast diagnostic tests (1–4). We have previously shown that the Amplidiag CarbaR+VRE assay displayed a high sensitivity and specificity on colonies of CP-GNB but failed to detect GES carbapenemase-producing organisms (GES-CPOs), which represent 11% of the carbapenemase-producing Pseudomonas aeruginosa (CP-Pa) in France (5). Moreover, this assay was not validated on clinical samples, such as rectal swabs.

Here, we have evaluated an updated assay, the Amplidiag Carba-R+MCR assay, which is a multiplex nucleic acid-based in vitro diagnostic test intended for the detection of CP-GNB, including GES carbapenemase-producing organisms (GES-CPOs) and colistin resistance gene mcr-1/2 from rectal swabs and from cultured colonies. The assay was evaluated during a retrospective evaluation on colonies of 215 GNB with well-characterized resistance mechanisms, during a prospective study on 51 consecutive enterobacterial isolates with reduced susceptibility to carbapenems referred to the French National Reference Center, and on extracted DNA from 100 rectal swabs (including 40 positives) sent to the hygiene unit for CP-GNB screening. This assay was used as recommended by the manufacturer (Mobidiag, Paris, France).

The Amplidiag CarbaR+MCR efficiently detected the big 5 carbapenemase families (KPC, including novel variants tested, such as KPC-5, KPC-6, KPC-12, KPC-14, and KPC-28; NDM, including NDM-4, NDM-5, NDM-6, NDM-7, and NDM-9; VIM, including VIM-4, VIM-9, and VIM-19; IMP, including IMP-8, IMP-11, and IMP-13; OXA-48-like, including OXA-162, OXA-181, OXA-232, and OXA-244) and the main acquired carbapenem-hydrolyzing oxacillinases from Acinetobacter baumannii (OXA-23, OXA-24/OXA-40, OXA-58, and the overexpressed OXA-51-like β-lactamase) in a similar manner to the Amplidiag CarbaR+VRE assay (Table 1). The sensitivity for all carbapenemases in cultured colonies was 99.2%; only one GES-CPO (GES-2-producing P. aeruginosa) was not detected. Overall, the specificity of detection of GES carbapenemases was not optimal since GES noncarbapenemase variants were also detected but with lower threshold cycle (CT) values. The three GES-7 producers have been falsely detected as carbapenemase producers. Indeed, the β-lactamase GES-7 does not host the mutation (Gly170Ser) conferring carbapenemase activity; its spectrum of hydrolysis is restricted to expended-spectrum cephalosporins (Table 1). However, CT values at 23 to 27 were obtained for the extended-spectrum β-lactamase (ESBL) GES-7, unlike GES-CPOs (GES-5 and GES-6) that displayed lower CT values of 12 to 17 (Table 1). Among the GES non-CPOs, the specificity was 38.5%, lowering the specificity of carbapenemase detection to 86.2% (Table 1). Plasmid-encoded colistin resistance genes mcr-1 and mcr-2 were perfectly detected (100% sensitivity; Table 1). As claimed by the manufacturer, MCR variants other than MCR-1 and -2 (here, MCR-3, -3.2, -4, and -5 [6] were not detected; 100% specificity; Table 1).

View this table:
  • View inline
  • View popup
TABLE 1

Global performances of the Amplidiag Carba+MCR kit on Enterobacteriaceae, P. aeruginosa, and Acinetobacter spp. colonies grown on MH agar isolates with decreased susceptibility to carbapenems or to colistina

DNA was extracted from rectal swabs, and the sensitivity was 92.5%; two NDM producers and one OXA-48 producer were not detected by the Amplidiag CarbaR+MCR. These 3 samples contained low concentrations of bacteria, requiring an overnight enrichment step in brain heart infusion medium supplemented with 0.5 µg/ml ertapenem for detection of two of them (Table 2). Conversely, one positive result was obtained with an AcOXA gene in a sample containing a cultivable OXA-48 producing Enterobacter cloacae isolate. In-house PCR confirmed the presence of the blaOXA-23 gene in the DNA extract, despite the absence of Acinetobacter spp. in the culture (7, 8). Accordingly, the global performances of the Amplidiag Carba-R+MCR assay were high (92 to 100% sensitivity and 86 to 100% specificity). Moreover, it can provide a result not only from colonies growing on Mueller-Hinton agar (MHA) or on selective screening medium but also from DNA extracted from clinical rectal swabs in less than three hours (1 h of DNA extraction and less than 2 h for PCR). The Amplidiag Carba-R+MCR assay is well adapted to the French epidemiology of CP-GNB, as it is able to detect 99.57% of CPEs (missing 13 IMI producers and one FRI-1 producer), 100% of CP A. baumannii (CP-Abs), and now 100% of CP-Pas (including the 11% of GES variants that were missed by the previous Carba-R+VRE assay) isolated over the period from 2012 to 2016 in France (9).

View this table:
  • View inline
  • View popup
TABLE 2

Global performances of the Amplidiag Carba+MCR kit on DNA extracted from clinical rectal swabsa

ACKNOWLEDGMENTS

This work was supported by the Assistance Publique–Hôpitaux de Paris (AP-HP), the University Paris-Sud, the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT) supported by a grant from the French National Research Agency (ANR-10-LABX-33), and by the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) DesInMBL (ANR-14-JAMR-002).

We declare that we have conflicts of interest.

  • Copyright © 2019 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Logan LK,
    2. Weinstein RA
    . 2017. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215:S28. doi:10.1093/infdis/jiw282.
    OpenUrlCrossRef
  2. 2.↵
    1. Gniadek TJ,
    2. Carroll KC,
    3. Simner PJ
    . 2016. Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle. J Clin Microbiol 54:1700–1710. doi:10.1128/JCM.03264-15.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Sun J,
    2. Zhang H,
    3. Liu Y-H,
    4. Feng Y
    . 2018. Towards understanding MCR-like colistin resistance. Trends Microbiol 26:794–808. doi:10.1016/j.tim.2018.02.006.
    OpenUrlCrossRef
  4. 4.↵
    1. Beyrouthy R,
    2. Robin F,
    3. Lessene A,
    4. Lacombat I,
    5. Dortet L,
    6. Naas T,
    7. Ponties V,
    8. Bonnet R
    . 2017. MCR-1 and OXA-48 in vivo acquisition in KPC-producing Escherichia coli after colistin treatment. Antimicrob Agents Chemother 61:e02540-16. doi:10.1128/AAC.02540-16.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Oueslati S,
    2. Girlich D,
    3. Dortet L,
    4. Naas T
    . 2018. Evaluation of the Amplidiag CarbaR+VRE kit for the accurate detection of carbapenemase-producing bacteria. J Clin Microbiol 56:01092-17. doi:10.1128/JCM.01092-17.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Girlich D,
    2. Naas T,
    3. Dortet L
    . 2018. Comparison of the Superpolymyxin™ and CHROMID Colistin R screening media for the detection of colistin-resistant Enterobacteriaceae from spiked rectal swabs. Antimicrob Agents Chemother AAC.01618-18. doi:10.1128/AAC.01618-18.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Bonnin RA,
    2. Nordmann P,
    3. Poirel L
    . 2013. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther 11:571–583. doi:10.1586/eri.13.38.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Poirel L,
    2. Figueiredo S,
    3. Cattoir V,
    4. Carattoli A,
    5. Nordmann P
    . 2008. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 52:1252–1256. doi:10.1128/AAC.01304-07.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Plésiat P,
    2. Cattoir V,
    3. Bonnet R,
    4. Naas T
    . 2016. 2016 Activity report. National Reference Center for Antibiotic Resistance. http://www.cnr-resistance-antibiotiques.fr/ressources/pages/Rapport_CNR_2016.pdf.
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria
Delphine Girlich, Sandrine Bernabeu, Victor Grosperrin, Isabelle Langlois, Christine Begasse, Nicolas Arangia, Elodie Creton, Garance Cotellon, Aimie Sauvadet, Laurent Dortet, Thierry Naas
Journal of Clinical Microbiology Feb 2019, 57 (3) e01800-18; DOI: 10.1128/JCM.01800-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria
Delphine Girlich, Sandrine Bernabeu, Victor Grosperrin, Isabelle Langlois, Christine Begasse, Nicolas Arangia, Elodie Creton, Garance Cotellon, Aimie Sauvadet, Laurent Dortet, Thierry Naas
Journal of Clinical Microbiology Feb 2019, 57 (3) e01800-18; DOI: 10.1128/JCM.01800-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X